ALCON N

ALC SIX Swiss Exchange Healthcare & Biotech Switzerland
53.66 Fr.
0.45 %

Alcon is a Swiss company specializing in ophthalmic medical , offering solutions for eye surgery and vision care.

Price history of ALCON N
Price history of ALCON N

Performance & Momentum

6 Months 13.25 %
1 Year 28.71 %
3 Years 27.72 %
5 Years 14.27 %

Strategic Analysis

ALCON N • 2026

Alcon holds a position as a global specialist in ophthalmic , with a business model centered on high-value medical devices for eye surgery and vision care. Its positioning combines a defensive healthcare component with exposure to markets supported by population ageing and rising visual care needs.

Strengths
  • Recognized ophthalmology specialist with expertise that is difficult to replicate
  • Exposure to long-term structural needs in cataract surgery and vision care
  • Addressable market supported by demographic ageing and demand for essential healthcare solutions
Weaknesses
  • Dependence on the medical equipment adoption cycle and healthcare facility investment
  • Weakened share performance across several time horizons, reflecting market lack of confidence in the group's acceleration
Momentum

Momentum appears decent but without a clearly convincing trend signal, with a recovery dynamic that remains fragile in the face of underlying pressure observed over recent years. Strategically, the stock may appeal to a long-term investor seeking defensive sector quality, but it remains worth monitoring until the stock-market rotation is accompanied by a clearer improvement in execution or market sentiment.

Similar stocks to ALCON N

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone